GENGENIUS
Live / Allowed — Fourth extension granted (statement of use) (as of 01 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Jul 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98099331
- Mark type
- Word mark
- Filed
- 24 Jul 2023
- Published for opposition
- 02 Apr 2024
- Attorney of record
- Yue (Robert) Xu
Goods and services
- Class 042 — Scientific and technological services: Scientific, technological and medical research services, namely, the service of providing gene synthesis, oligo synthesis, cloning, protein expression, peptide synthesis and antibody production, genome modification, cell line establishment, animal model establishment, in vivo and in vitro assays; Product quality testing; Biochemical research and analysis; Chemical analysis; DNA screening for scientific research purposes; Biological cloning services; Biological research and analysis; Medical and scientific research, namely, conducting clinical trials for others; Material testing; Computer system design
Owner
- Nanjing GenScript Biotech Co., Ltd., Jiangsu Province,, CN
- Nanjing GenScript Biotech Co., Ltd., Jiangsu Province,, CN
Prosecution history
- 02 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jun 2026 — SOU EXTENSION 4 GRANTED
- 01 Jun 2026 — SOU EXTENSION 4 FILED
- 01 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Nov 2025 — SOU EXTENSION 3 GRANTED
- 30 Nov 2025 — SOU EXTENSION 3 FILED
- 30 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 May 2025 — SOU EXTENSION 2 GRANTED
- 29 May 2025 — SOU EXTENSION 2 FILED
- 29 May 2025 — SOU TEAS EXTENSION RECEIVED
- 23 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Oct 2024 — SOU EXTENSION 1 GRANTED
- 23 Oct 2024 — SOU EXTENSION 1 FILED